E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/24/2013 in the Prospect News PIPE Daily.

International Stem Cell seals $2.03 million private placement of stock

Deal also includes warrants; common shares sold at $0.20 per share

By Devika Patel

Knoxville, Tenn., Jan. 24 - International Stem Cell Corp. raised $2.03 million in a private placement of stock with insiders Andrey Semechkin and Simon Craw on Jan. 22, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 10,125,000 common shares at $0.20 apiece. The price per share is a 16.67% discount to the Jan. 18 closing share price of $0.24.

The two investors also received warrants to purchase 50% of the number of shares purchased in the offering, or 5,062,500 shares. The warrants are exercisable at $0.20 for five years. The warrant strike price is also a 16.67% discount to the Jan. 18 closing share price.

Proceeds will be used for working capital purposes.

International Stem Cell is a biotechnology company based in Carlsbad, Calif.

Issuer:International Stem Cell Corp.
Issue:Common shares
Amount:$2,025,000
Shares:10,125,000
Price:$0.20
Warrants:50% coverage (for 5,062,500 shares)
Warrant expiration:Five years
Warrant strike price:$0.20
Investors:Andrey Semechkin and Simon Craw
Settlement date:Jan. 22
Stock symbol:OTCBB: ISCO
Stock price:$0.24 at close Jan. 18
Market capitalization:$19.23 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.